Literature DB >> 15910734

Catalytic turnover of pyrene by CYP3A4: evidence that cytochrome b5 directly induces positive cooperativity.

Monica I Jushchyshyn1, J Matthew Hutzler, Michael L Schrag, Larry C Wienkers.   

Abstract

The metabolism of pyrene to hydroxypyrene by CYP3A4 was investigated to determine the effect of cytochrome b5 (b5) on turnover kinetics. In the absence of b5, formation of hydroxypyrene in in vitro incubations showed a biphasic substrate-velocity curve where K(m1) and V(max1) were 1.3 microM and 0.5 pmol/min/pmol P450, respectively. The addition of testosterone to the incubation mixture completely abolished the second phase to yield a typical, hyperbolic curve, presumably through the disruption in the formation of a pi-pi stacked pyrene complex within the CYP3A4 active site. Finally, the addition of b5 yielded an increase hydroxypyrene formation that resulted in a sigmoidal substrate velocity curve. The V(max) was 15.7 pmol/min/pmol P450, the K(m) was 7.5 microM, and the Hill coefficient was greater than two. This demonstrated that b5 could directly induce positive cooperativity on CYP3A4 and that this biological factor needs to be carefully considered when included in in vitro P450 reactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15910734     DOI: 10.1016/j.abb.2005.02.027

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  CYP2D6-CYP2C9 protein-protein interactions and isoform-selective effects on substrate binding and catalysis.

Authors:  Murali Subramanian; Michael Low; Charles W Locuson; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2009-05-15       Impact factor: 3.922

2.  Heterotropic activation of the midazolam hydroxylase activity of CYP3A by a positive allosteric modulator of mGlu5: in vitro to in vivo translation and potential impact on clinically relevant drug-drug interactions.

Authors:  Anna L Blobaum; Thomas M Bridges; Frank W Byers; Mark L Turlington; Margrith E Mattmann; Ryan D Morrison; Claire Mackie; Hilde Lavreysen; José M Bartolomé; Gregor J Macdonald; Thomas Steckler; Carrie K Jones; Colleen M Niswender; P Jeffrey Conn; Craig W Lindsley; Shaun R Stauffer; J Scott Daniels
Journal:  Drug Metab Dispos       Date:  2013-09-03       Impact factor: 3.922

3.  Effects of the CYP2B6*6 allele on catalytic properties and inhibition of CYP2B6 in vitro: implication for the mechanism of reduced efavirenz metabolism and other CYP2B6 substrates in vivo.

Authors:  Cong Xu; Evan T Ogburn; Yingying Guo; Zeruesenay Desta
Journal:  Drug Metab Dispos       Date:  2012-01-09       Impact factor: 3.922

4.  Multiple substrate-binding sites are retained in cytochrome P450 3A4 mutants with decreased cooperativity.

Authors:  Harshica Fernando; Jessica A O Rumfeldt; Nadezhda Y Davydova; James R Halpert; Dmitri R Davydov
Journal:  Xenobiotica       Date:  2010-12-14       Impact factor: 1.908

5.  Cross-linking mass spectrometry and mutagenesis confirm the functional importance of surface interactions between CYP3A4 and holo/apo cytochrome b(5).

Authors:  Chunsheng Zhao; Qiuxia Gao; Arthur G Roberts; Scott A Shaffer; Catalin E Doneanu; Song Xue; David R Goodlett; Sidney D Nelson; William M Atkins
Journal:  Biochemistry       Date:  2012-11-14       Impact factor: 3.162

6.  Variability in Human In Vitro Enzyme Kinetics.

Authors:  Christopher R Gibson; Ying-Hong Wang; Ninad Varkhede; Bennett Ma
Journal:  Methods Mol Biol       Date:  2021

7.  A Screen of Approved Drugs Identifies the Androgen Receptor Antagonist Flutamide and Its Pharmacologically Active Metabolite 2-Hydroxy-Flutamide as Heterotropic Activators of Cytochrome P450 3A In Vitro and In Vivo.

Authors:  Anna L Blobaum; Frank W Byers; Thomas M Bridges; Charles W Locuson; P Jeffrey Conn; Craig W Lindsley; J Scott Daniels
Journal:  Drug Metab Dispos       Date:  2015-08-11       Impact factor: 3.922

8.  CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis.

Authors:  Charles W Locuson; Larry C Wienkers; Jeffrey P Jones; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2007-04-19       Impact factor: 3.922

9.  Effect of CYP3A5 expression on the inhibition of CYP3A-catalyzed drug metabolism: impact on modeling CYP3A-mediated drug-drug interactions.

Authors:  Yoshiyuki Shirasaka; Shu-Ying Chang; Mary F Grubb; Chi-Chi Peng; Kenneth E Thummel; Nina Isoherranen; A David Rodrigues
Journal:  Drug Metab Dispos       Date:  2013-05-30       Impact factor: 3.922

10.  Cooperativity of cytochrome P450 1A2: interactions of 1,4-phenylene diisocyanide and 1-isopropoxy-4-nitrobenzene.

Authors:  Emre M Isin; Christal D Sohl; Robert L Eoff; F Peter Guengerich
Journal:  Arch Biochem Biophys       Date:  2008-02-29       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.